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Th2 cytokinesVirus infection may contribute to asthma pathogenesis. In turn, a Th2-polarized pulmonary environment
may increase host susceptibility to infection. We used a cockroach antigen (CRA) model of allergic airway
disease to test the hypothesis that Th2 cytokine overproduction increases susceptibility to mouse adenovirus
type 1 (MAV-1). CRA sensitization led to upregulated lung expression of IL-4 and IL-13, lung cellular
inﬂammation, and exaggerated airway mucus production. Following intranasal MAV-1 infection, lung cellular
inﬂammation was more pronounced in CRA-sensitized mice than in unsensitized mice at 7 days post-
infection but not at a later time point. CRA sensitization did not signiﬁcantly suppress lung IFN-γ expression,
and lung IFN-γ expression was upregulated in both CRA-sensitized mice and unsensitized mice over the
course of MAV-1 infection. Despite CRA-induced differences in pulmonary inﬂammation, MAV-1 viral loads
in lung and spleen and MAV-1 gene expression in the lung did not differ between CRA-sensitized and
unsensitized mice. Our data therefore suggest that MAV-1 pathogenesis is not affected directly or indirectly
by the Th2 polarization associated with allergic airway disease.© 2009 Elsevier Inc. All rights reserved.Introduction
Asthma is a chronic disorder of the airways characterized by
inﬂammation, increased airway hyperresponsiveness, and obstruction
of air ﬂow (reviewed in Eisenbarth et al., 2004). Asthma prevalence
continues to rise among0 to 17 year-olds, increasing froman estimated
3.6% to 6.2% between 1980 to 1996,with the greatest increase observed
in 0 to 4 year-olds (Akinbami and Schoendorf, 2002). Acute viral
respiratory infections act as triggers for asthma exacerbation, with
speciﬁc viruses isolated in up to 80–85% of asthma exacerbations in
children (Johnston, 2007; Traves and Proud, 2007). Viral infections
may also be risk factors for subsequent development of asthma.
Children infected with respiratory syncytial virus (RSV) as infants are
more likely to develop asthma compared to children without RSV
infection (Sigurs et al., 2000), although it is unclear if asthma develops
as a direct result of RSV infection or if the virus targets childrenwho are
already predisposed to develop obstructive airway disease (Peebles,
2004; Perez-Yarza et al., 2007). Some reports suggest that persistent
adenovirus infection serves as a risk factor for childhood asthma
(Macek et al., 1994; Marin et al., 2000).
Chronic inﬂammation characteristic of asthma is dependent on
prototypic T-helper type (Th)2 cytokines such as interleukin (IL)-4search Building I, 1150 West
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ll rights reserved.and IL-13 (Chatila, 2004). IL-4 and IL-13 activate the intracellular
signal transducer and activator of transcription (STAT)6, one key
mediator in pathways linked to allergic inﬂammation and mucus
production (Chatila, 2004). Data from mouse models suggest that the
Th2-polarizedmicroenvironment in asthmamay act as a risk factor for
infection. For instance, clearance of Pseudomonas aeruginosa from the
lungs is impaired in mice with allergic airway inﬂammation induced
by ovalbumin sensitization (Beisswenger et al., 2006). There is also
evidence that susceptibility to viral infection is increased in the
presence of elevated levels of Th2 cytokines. Mice treated with IL-4
following inﬂuenza virus infection show increased viral titers in the
lungs compared to controls, and clearance of virus from the lungs is
impaired (Moran et al., 1996). Mice constitutively overexpressing IL-4
in the lungs also exhibit a delay in RSV clearance (Fischer et al., 1997).
Studies of human adenovirus pathogenesis are limited by the strict
species-speciﬁcities of the adenoviruses. Little is known regarding the
effects of Th2 cytokines on adenovirus pathogenesis. Mouse adeno-
virus type 1 (MAV-1) provides an excellent tool to study the
pathogenesis of an adenovirus in its natural host. We have previously
established MAV-1 as a model of adenovirus respiratory infection
(Weinberg et al., 2007;Weinberg et al., 2005). Herewe usedMAV-1 to
test the hypothesis that Th2 polarization increases susceptibility to
respiratory infectionwith an adenovirus. We examine the effects of in
vivo Th2 polarization on MAV-1 pathogenesis using allergic airway
sensitization with cockroach antigen (CRA). Our results suggest that
MAV-1 is relatively resistant to the effects of exaggerated Th2 cytokine
production.
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Effects of Th2 polarization on MAV-1-induced pulmonary inﬂammation
Cockroach antigen (CRA) sensitization has been established as a
model of allergic airway disease, with increased airway hyperreacti-
vity, mucus production, peribronchial inﬂammation, and upregulation
of lung IL-4 and IL-13 in sensitized mice compared to control animals
(Berlin et al., 2006). We used CRA to modify the pulmonary
environment in mice prior to infection with MAV-1. After an initial
systemic sensitization, mice were repeatedly challenged intranasally
(i.n.) with CRA over an 18-day period prior to infection and during the
course of infection (summarized in Fig. 1A) in order to localize the
response to the airways. We used RT-qPCR to assess the effect of CRA
sensitization on expression in the lung of IL-4 and IL-13 (Fig. 1B).
Following sensitization but prior to infection, expression of each Th2
cytokine was signiﬁcantly increased in the lungs of CRA-sensitized
mice compared to unsensitized control animals that received
phosphate-buffered saline (PBS; 68±19 fold change from PBS-
treated control animals for IL-4; 1595±591 fold change for IL-13;
mean±S.E.M.; Pb0.01 in each case). These data are similar to studies
using CRA sensitization-induced allergic airway disease in which IL-4
and IL-13 protein levels were increased in both lung homogenate and
bronchoalveolar lavage ﬂuid of CRA-sensitized mice compared to
unsensitized controls (Lindell et al., 2008). Lung expression of both
IL-4 and IL-13 continued to be increased in CRA-sensitized mice
compared to unsensitized control mice at all time points following
MAV-1 infection (data not shown).
We also assessed lung expression of interferon (IFN)-γ following the
initial 18-day CRA sensitization and throughout the course of MAV-1
infection (Fig. 1C). Somewhat surprisingly, CRA sensitization did not
initially suppress IFN-γ expression in the lungs. Following sensitization
but prior to infection, lung IFN-γ expression was instead slightly
upregulated in CRA-sensitized mice compared to unsensitized controlFig. 1. Cytokine expression in the lungs of CRA-sensitized mice. (A) Experimental protocol fo
subcutaneously with CRA at day 0 and subsequently received intranasal CRA at the time poin
each time point. All animals were infected intranasally with MAV-1 on day 18. Animals were
10 d.p.i. (corresponding to experiment days 22, 25 and 28). (B) RT-qPCR was used to assess IL
day 18, immediately prior to MAV-1 infection. Data for ﬁvemice per group are presented as m
IFN-γ expression in the lungs of CRA-sensitized and unsensitized control mice prior to infecti
presented as fold change from expression levels measured in unsensitized control mice, whic
ten mice per group are combined from three independent experiments and presented as mmice (Fig. 1C, day 0; 3.4±1.6 fold change from PBS-treated control
animals), although this difference was not statistically signiﬁcant. Lung
IFN-γ expression was upregulated in both CRA-sensitized and unsensi-
tized control mice following MAV-1 infection. IFN-γ expression was
slightly lower in CRA-sensitized mice compared to unsensitized control
mice following MAV-1 infection, but there were no statistically
signiﬁcant differences between groups at any time point.
Similar to our earlier ﬁndings (Weinberg et al., 2005), MAV-1
infection of unsensitized mice induced a mild pneumonitis (Fig. 2A,
left panels). Mononuclear cells began to accumulate around medium
and large airways of infected mice as early as 4 d.p.i., and increasing
peribronchial inﬁltrates were noted at 7 and 10 d.p.i. By itself, CRA
sensitization also induced a cellular inﬂammatory response in the
lungs, with inﬂammatory cells surrounding airways of sensitized mice
(Fig. 2A, uppermost right panel). Cellular inﬂammation became more
extensive in CRA-sensitized mice over the course of MAV-1 infection
(Fig. 2A, right panels). MAV-1-induced cellular inﬂammation was
more pronounced in the lungs of CRA-sensitized mice compared to
control mice at 4 and 7 d.p.i. By 10 d.p.i., lungs of MAV-1-infected
control mice were histologically similar to lungs of MAV-1-infected,
CRA-sensitized mice.
Pathology index scores (Table 1) quantifying lung inﬂammation in
available lung sections reﬂected the qualitative assessments of lung
inﬂammation described above. As shown in Fig. 2B, lung pathology
increased over time in both CRA-sensitized and unsensitized control
mice over the course of MAV-1 infection. Pathology was greater in
CRA-sensitized mice compared to unsensitized control mice at every
time point before and after MAV-1 infection, but only at 7 d.p.i. was
this difference statistically signiﬁcant.
Mucus production in airways of CRA-sensitized and MAV-1-infected mice
Mucus overproduction is a common feature of asthma (Evans and
Koo, 2008), and respiratory viral infection is often associated withr in vivo CRA sensitization and infection. Animals were sensitized intraperitoneally and
ts indicated with an asterisk. Unsensitized control mice were instead treated with PBS at
euthanized and organs were harvested prior to infection on day 18 and then at 4, 7 and
-4 and IL-13 expression in the lungs of CRA-sensitized and unsensitized control mice on
eans±S.E.M. ⁎⁎Pb0.01 compared to unsensitized mice. (C) RT-qPCR was used to assess
on and then at the indicated time points post-infection. Data for CRA-sensitized mice are
h are set at 1 for each time point (indicated with horizontal dashed line). Data for ﬁve to
eans±S.E.M.
Fig. 2. Cellular inﬂammation in lungs of CRA-sensitized, MAV-1 infected mice. Mice were sensitized with CRA or treated with PBS according to the schedule outlined in Fig. 1A. All
mice were then infected intranasally with MAV-1. Lungs were harvested from CRA-sensitized and unsensitized control mice at the indicated time points. (A) Parafﬁn-embedded lung
sections were stained with hematoxylin and eosin to evaluate cellular inﬁltrates. Images are characteristic of a minimum of two mice per group per time point. Scale bars, 100 μm.
(B) Pathology index scores were generated to quantify cellular inﬂammation in the lungs of CRA-sensitized and unsensitized control mice. Data are presented as means±S.E.M. at
each time point (n=2 at 0 and 10 d.p.i., n=4 at 4 and 7 d.p.i.). ⁎Pb0.05 compared to unsensitized mice at the same time point.
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et al., 2006). There are no reports that speciﬁcally detail mucus
production induced by infection with either a human adenovirus or
MAV-1. We ﬁrst assessed airway mucus production using Periodic
acid-Schiff (PAS) staining. No mucus production was evident in lungs
of unsensitized, uninfectedmice (Fig. 3A, upper left panel). At 10 d.p.i.,
scattered sparse staining in respiratory epithelial cells suggested that
mucus productionwas induced to a limited extent by MAV-1 infection
(Fig. 3A, bottom left panel). Prior to infection, mucus production
evaluated by PAS stainingwas dramatically enhanced in the airways of
CRA-sensitized mice compared to unsensitized control mice (Fig. 3A,
compare upper left and upper right panels). Mucus production
became even more pronounced in respiratory epithelial cells over
the course of MAV-1 infection in the setting of ongoing CRA exposure
(Fig. 3A, right panels). These qualitative assessments correlated with
quantitative measurements of PAS staining in the lungs. The per-
centage of airways with PAS staining in respiratory epithelial cells wasTable 1
Quantiﬁcation of cellular inﬂammation in histologic specimens.
Scorea Cellular inﬁltrates
around airway lumens
Pneumonitis
0 No inﬁltrates No inﬁltrates
1 1 to 3 cell diameters thick Increased cells visible only at high power
2 4 to 10 cell diameters thick Easily seen cellular inﬁltrates
3 N10 cell diameters thick Extensive consolidation by inﬂammatory cells
a A score from 0 to 3 was given for each of the two categories. The score for each
category was multiplied by a number reﬂecting the extent of involvement in the
specimen (5% to 25%=1, N25% to 50%=2, N50%=3). The ﬁnal pathology index score
was obtained by adding together values for each category, resulting in a total score that
could range from 0 to 18.consistently greater in CRA-sensitized mice than in unsensitized
control mice, both before and following MAV-1 infection (Fig. 3B).
The percentage of PAS-positive airway lumens increased over the ﬁrst
7 d.p.i. in CRA-sensitized mice but remained very low in unsensitized
control mice over the course of infection.
We conﬁrmed the exaggerated mucus production in CRA-sensitized
mice using RT-qPCR to measure the expression of muc5ac and gob5,
genes encoding major components of mucus in the airways (Fig. 3C).
Following the initial 18-day CRA sensitizationprotocol, the expression of
each gene was upregulated in CRA-sensitized mice compared to PBS-
treated mice (18.9±9.1 fold change from PBS-treated control animals
formuc5ac; 8.1±2.7 for gob5; Pb0.01 in each case).
Effects of CRA sensitization on MAV-1 viral loads and viral gene
expression
To determine if the Th2-skewed immunologic environment in CRA-
sensitized mice increased susceptibility to MAV-1 respiratory infec-
tion,weusedqPCR tomeasureMAV-1 viral loads at various timepoints
following infection (Fig. 4A). BALB/c mice are typically much more
resistant to MAV-1 than are other inbred mouse strains (Guida et al.,
1995; Spindler et al., 2001), and we were not able to consistently
isolate infectious virus from the lungs of BALB/c mice using plaque
assay (data not shown). We therefore used qPCR measurements of
MAV-1 DNA as amore sensitiveway to quantify viral loads in the lungs
of infected mice. CRA sensitization did not affect the amount of viral
DNA detected in the lungs at an early time point (4 d.p.i.), a time point
corresponding to the typical peak of lung viral loads (7 d.p.i.), or a later
timepointwhenviral DNA is being cleared from the lungs (10d.p.i.). To
provide an additional correlate of viral activity in the lungs, we used
Fig. 3.Mucus production in lungs of CRA-sensitized, MAV-1 infectedmice. Micewere sensitizedwith CRA or treatedwith PBS according to the schedule outlined in Fig.1A. All mice were
then infected intranasally withMAV-1. Lungs were harvested from CRA-sensitized and unsensitized control mice at the indicated time points. (A) Lung sections were stained with PAS to
evaluatemucusproduction in the lungs. Pronounced stainingofmucus is present in respiratory epithelial cells lining the airways of CRA-sensitizedmice (right panels). Scattered staining is
present in the respiratory epithelial cells lining the airways of PBS-treated, MAV-1-infected mice at 7 and 10 d.p.i. (left panels, arrows indicate examples of PAS staining). Images are
characteristic of a minimum of two mice per group per time point. Scale bars, 100 μm. (B) Lung sections were examined to quantify the percentage of airway lumens with positive PAS
staining. Data are presented asmeans±S.E.M. at each time point (n=2at 0 and 10 d.p.i., n=4 at 4 and 7 d.p.i.). ⁎Pb0.05 and ⁎⁎⁎Pb0.001 compared to unsensitizedmice at the same time
point. (C) RT-qPCRwas used to assessmuc5ac and gob5 expression in the lungs of CRA-sensitized and unsensitized control mice on day 18, immediately prior to MAV-1 infection. Data for
CRA-sensitizedmice are presented as fold change from expression levels measured in unsensitized control mice, which are set at 1 for each time point (indicated with horizontal dashed
line). Data for ﬁve mice per group are presented as means±S.E.M. ⁎⁎Pb0.01 compared to unsensitized mice at the same time point.
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to the pattern observed with DNAviral loads, therewas no statistically
signiﬁcant difference between viral gene expression in the lungs of
CRA-sensitized mice compared to control mice at any time point.
Of note, the viral loads that were measured at 7 d.p.i. in CRA-
sensitized and unsensitized control mice in these experiments
(Fig. 4A) were similar in magnitude to viral loads measured at
7 d.p.i. in separate experiments demonstrating a time course of
MAV-1 respiratory infection (Fig. 4C). Lung viral loads at 7 d.p.i.
in the CRA experiments (Fig. 4A) were approximately two logs
greater than those measured in separate experiments at 1 d.p.i.
(Fig. 4C). This accumulation of viral DNA, in conjunction with the
detection of increasing amounts of viral gene expression in the
lung (Fig. 4B) and the dissemination of virus to the spleen at a
later time point (Fig. 4D and text below), all strongly suggest that
MAV-1 actively replicates in the lungs of BALB/c mice.
Lastly, to determine whether CRA sensitization affected the
dissemination of MAV-1 out of the lung, we measured viral loads in
the spleen, which is an additional target organ forMAV-1 following i.n.
inoculation (Kajon et al., 1998). We detected no statistically signiﬁcant
differences in spleen viral loads in CRA-sensitized mice compared to
PBS-treated control mice at any time point (Fig. 4D). Together, these
data suggest that CRA sensitization and the resulting Th2-skewed
immunologic environment in the lunghadno effect on viral replication
in the lung, clearance of virus from the lung, or viral dissemination out
of the lung.Discussion
Aberrant inﬂammatory responses in the lung such as the Th2-
polarized environment seen in asthma may alter an individual's
susceptibility to a variety of pathogens. Previous work in animal and
cell culturemodels suggests that Th2-skewed inﬂammatory responses
alter susceptibility to some bacterial and viral pathogens. For instance,
preincubation in vitro of primary human bronchial epithelial cells
with recombinant IL-4 or IL-13 increased the amount of Pseudomonas
aeruginosa recovered at 24 h.p.i. (Beisswenger et al., 2006). In the
same study, allergic sensitization of mice with ovalbumin increased
the amount of viable bacteria recovered from the lungs compared to
amounts recovered from unsensitized animals. Treatment of mice
with IL-4 delays the clearance of inﬂuenza virus from the lungs
(Moran et al., 1996). Similarly, IL-4-overexpressing transgenic mice
show delayed clearance of RSV following i.n. infection (Fischer et al.,
1997). This effect is associated with diminished RSV-speciﬁc cytolytic
activity of lung lymphocytes.
Similar studies examining the effect of Th2 polarization on human
adenovirus pathogenesis have not yet been done, in part because of
the strict species-speciﬁcity of the adenoviruses. In this study, we
investigated the effects of Th2 polarization onMAV-1 pathogenesis. In
a mouse model of allergic airway disease, CRA sensitization
substantially upregulated lung expression of IL-4 and IL-13, induced
a cellular inﬂammatory response in the lungs, and increased airway
mucus production. MAV-1 viral gene expression in the lungs and
Fig. 4. Effects of CRA sensitization on MAV-1 viral loads and viral gene expression. (A, B and D) Mice were sensitized with CRA or treated with PBS according to the schedule outlined
in Fig. 1A. All mice were then infected intranasally with MAV-1. DNA and RNAwere extracted from lungs and DNAwas extracted from spleens harvested at the indicated time points.
(C) In a separate experiment, naïve mice were infected intranasally with MAV-1 and DNA was extracted from lungs at the indicated time points. qPCR was used to quantify MAV-1
genome copies in DNA from lung (A,C) and spleen (D). RT-qPCR was used to quantify copy numbers of MAV-1 hexon and GAPDH transcripts in the lungs (B). Individual circles
represent values for individual mice and horizontal bars represent means for each group. DNAviral load data are expressed as copies of MAV-1 genome per 100 ng of input DNA. Viral
gene expression data are expressed as copies of MAV-1 hexon per 106 copies of GAPDH. Indicated P values were obtained by two-way ANOVAwith Bonferroni's multiple comparison
tests. Where not indicated, P values were N0.05.
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sensitization, despite dramatic differences in pulmonary inﬂamma-
tion at baseline and the slight suppression of lung IFN-γ responses at
later time points in CRA-sensitized animals. Taken together, our data
suggest that MAV-1 is relatively resistant to the effects of classical Th2
cytokines in the lungs.
In theory, there are many ways in which exaggerated Th2 cytokine
signaling could directly inﬂuence viral pathogenesis. STAT6 phospho-
rylation is the major intracellular event triggered by binding of IL-4 or
IL-13 to the IL4Rα receptor (Heller et al., 2004; Kuperman et al., 1998).
Phosphorylated STAT6 homodimerizes and translocates to the
nucleus, where it initiates gene transcription by binding to speciﬁc
DNAmotifs (Heller et al., 2004; Kuperman et al., 1998). Transcriptional
activation by STAT6 involves interactions with the cofactors cAMP
response element-binding binding protein (CBP) and p300 (Gingras
et al., 1999; McDonald and Reich, 1999). Human adenovirus E1A,
which also binds to CBP and p300, inhibits CBP/p300-mediated STAT6
coactivation and represses IL-4-induced target gene activity (Gingras
et al., 1999; McDonald and Reich, 1999). While adenovirus infection
may thus inhibit subsequent cytokine-stimulated STAT6 activity, it is
plausible that viral gene transcription could be enhanced by STAT6
activated by IL-4 and/or IL-13. Multiple transcription factors in
addition to STAT6 are activated in the presence of “proasthmatic
cytokines” such as IL-4 and IL-13 (Panebra et al., 2007), so other
pathways may contribute to Th2 cytokine enhancement of adenovirus
replication. It is also possible that IL-4 and IL-13 suppress the
production of cytokines or other factors that inhibit viral replication
in an autocrine or paracrinemanner. Th2 cytokine-mediated increases
in the expression of a virus receptor, as has been demonstrated forICAM-1, a rhinovirus receptor (Bianco et al., 19980; Bianco et al.,
2000), could also contribute to changes in viral pathogenesis.
There are alsomanyways inwhich Th2 polarization could indirectly
inﬂuence viral pathogenesis, modulating host immune responses in
ways that could be conducive to viral replication. For instance, alveolar
macrophages (AMs) play a critical role in mediating the clearance of
adenovirus from the lungs via phagocytosis (Carey et al., 2007;
Zsengeller et al., 2000) in addition to recruiting and activating other
cells to the site of infection (Zhou et al., 1994; Zsengeller et al., 2000).
IL-4 can interfere with AM function (Zhou et al., 1994), potentially
contributing to increased viral replication in the lungs. IL-4 and IL-13
may also affect viral pathogenesis by altering lymphocyte function. Th2
cytokines inhibit the function of Th1 lymphocytes through interference
with memory CTL expansion or recruitment of speciﬁc memory CD8+T
cells (Bot et al., 2000). Speciﬁc roles for T lymphocytes have not yet been
deﬁned in MAV-1 respiratory infection, and in this study we did not
phenotype the inﬂammatory cells inﬁltrating the lungs of infectedmice
in order to determine if T lymphocytes contribute to MAV-1-induced
responses in the lungs. However, T lymphocytes are involved in MAV-1
pathogenesis following i.p. infection, playing a role in the acute
immunopathology observed in MAV-1 encephalomyelitis and contri-
buting to long-term host survival following intraperitoneal (i.p.)
infection (Moore et al., 2003). In our model of allergic airway disease,
increased IL-4 and IL-13 in the lungs could foster an atmosphere in
which lymphocytes critical for the control of viral infection are not
effectively recruited to the airways, are impaired in their function, or
both. Based on our in vivo data, however, any such change induced by
CRA sensitization was not sufﬁcient to substantially alter MAV-1
pathogenesis.
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upregulated, although not to a statistically signiﬁcant degree,
following CRA sensitization. This subtle ﬁnding is not unique to our
report, as CRA-associated IFN-γ upregulation in the lung was reported
in a study using a similar mouse model of chronic CRA exposure
(Lindell et al., 2008). The particular cell types producing increased
levels of IFN-γ in this model have not yet been identiﬁed (Nicholas
Lukacs, personal communication). MAV-1 is relatively resistant to the
effects of type I and type II IFNs in mouse L929 cells (Kajon and
Spindler, 2000). However, mice deﬁcient for IFN-γ production are
more susceptible to systemic MAV-1 infection (Kathy Spindler,
personal communication), suggesting that IFN-γ may contribute to
the control of MAV-1 infection in some in vivo settings. IFN-γ
overproduction caused by latent gammaherpesvirus infection is
associated with decreased MAV-1 lung viral loads (Nguyen et al.,
2008). IFN-γ expression was readily detected in both CRA-sensitized
mice and unsensitized control mice following MAV-1 infection. It is
possible that this IFN-γ expression was sufﬁcient to contribute to
control of MAV-1 such that no differences in viral loads or viral gene
expression were observed.
Mucus overproduction in the lung is a common feature of asthma
(Evans and Koo, 2008). The results of our study suggest that acute
MAV-1 infection did not induce mucus production in the lungs of
unsensitized mice. Mucus production increased in the lungs of CRA-
sensitized mice following MAV-1 infection, but not in the lungs of
unsensitized, MAV-1-infected mice. It is possible that allergic airway
disease induced by CRA sensitization primes the lungs for exaggerated
MAV-1-induced mucus production. Likewise, this type of synergy
between CRA sensitization and MAV-1 infection, though not speciﬁ-
cally evaluated in these studies, may account for some of the observed
differences in pulmonary inﬂammation between unsensitized and
CRA-sensitized animals (as with lung IFN-γ expression in Fig. 1C and
lung cellular inﬂammation in Fig. 2). However, it seems more likely
that increased mucus production following MAV-1 infection was due
to the ongoing exposure to CRA, a potent stimulus for mucus pro-
duction by itself.
While increased mucus production could interfere with efﬁcient
clearance of a pathogen from the lungs, it is also possible that mucus
overproduction could inhibit respiratory infection by interfering with the
accessof avirus to its target receptoron the luminal surfaceof a respiratory
epithelial cell. MAV-1 does not use themouse equivalent of the coxsackie-
adenovirus receptor usedbymanyhumanadenovirus serotypes (Lenaerts
et al., 2006). Similar to human adenovirus type 5, integrin and heparan
sulfate glycosaminoglycans playa role in interactions betweenMAV-1 and
target cells (Raman et al., 2009). Consistent with the ability of mucus to
inhibit virus access to target receptors, MAV-1 infection of mice deﬁcient
in Muc1, a tethered mucin present on the luminal surface of respiratory
epithelial cells (Gendler, 2001), results in higher lung viral loads than in
wild type mice (Ngyuen and Weinberg, manuscript in preparation).
Inhibitory effects ofmucus overproduction could counterbalance any pro-
viral effects of Th2 cytokine overproduction induced by CRA sensitization,
leading to an apparent overall lack of an effect on MAV-1 pathogenesis as
we found in this study.
In summary, we demonstrate that CRA sensitization of mice leads to
a Th2-polarized pulmonary environment, with exaggerated expression
of IL-4 and IL-13 and increased mucus production in the lung. In
addition, CRA sensitizationwas associatedwith the suppressionof IFN-γ
responses induced by MAV-1 respiratory infection. Unlike previous
reports describing increased susceptibility to respiratory infection with
bacterial and unrelated viral pathogens in settings of increased Th2
cytokine levels, Th2 polarization induced by CRA sensitization did not
increase susceptibility toMAV-1 infection. Thus, while CRA sensitization
induced robust changes in pulmonary inﬂammation characteristic of
allergic airway disease, these changes in pulmonary immune function
did not substantially affect the pathogenesis of MAV-1 respiratory
infection.Materials and methods
Virus and cell lines
MAV-1was grown inNIH 3T6ﬁbroblasts and titerswere determined
by plaque assay as previously described (Cauthen et al., 2007).
Cockroach antigen sensitization and in vivo infection
All animal work was approved by the University of Michigan
Committee on the Use and Care of Animals. An allergic airway model
using CRA sensitization (summarized in Fig. 1A) was modiﬁed from
that previously described (Berlin et al., 2006). Four to 6 week-old
female BALB/c mice (Jackson Laboratories) were housed in speciﬁc
pathogen-free conditions. Under ketamine/xylazine anesthesia, mice
were sensitized i.p. and subcutaneously (s.q.) with a 1:1 emulsion of
CRA (∼2 μg/mouse, Hollister-Steir) and incomplete Freund's Adjuvant
(Sigma). On days 14 and 17 following the initial sensitization, themice
were anesthetized and challenged i.n. with CRA (∼0.8 μg/mouse)
diluted to 40 μl with phosphate-buffered saline (PBS). On day 18, mice
were anesthetized and inoculated i.n. with 105 pfu of MAV-1 diluted to
a total volume of 40 μl with sterile phosphate-buffered saline (PBS).
Mice received additional i.n. challenges of CRA on days 21, 24, and 27,
corresponding to 3, 6, and 9 d.p.i. Unsensitized control mice were
inoculatedwith equivalent amounts of PBS instead of CRA at each time
point. At baseline following sensitization but before infection, and
then again at 4, 7 and 10 d.p.i., organs were harvested and snap-frozen
on dry ice and stored at−80 °C. In separate experiments, unsensitized
mice were infected with 105 PFU of MAV-1 as detailed above. Organs
were harvested and snap-frozen at baseline prior to infection and then
at multiple time points post-infection.
DNA and RNA isolation from mouse organs
DNA was extracted from the middle lobe of the right lung and
approximately 30 mg of the spleen using the DNeasy® Tissue Kit
(Qiagen Inc.). Total RNA was extracted from lungs as previously
described (Nguyen et al., 2008). In brief, approximately one-third of
each lung was homogenized using sterile glass beads in a mini
Beadbeater (Biospec Products) for 30 s in 1 ml of TRIzol. RNAwas then
isolated from the homogenates according to the manufacturer's
protocol.
Analysis of viral load and viral gene expression
MAV-1 viral loads were measured in organs using quantitative
real-time PCR (qPCR) as previously described (Nguyen et al., 2008).
Primers and probe were used to detect a 59-bp region of the MAV-1
EIA gene as follows: forward 5′-GCACTCCATGGCAGGATTCT-3′, reverse
5′-GGTCGAAGCAGACGGTTCTTC-3′, and probe 5′-FAM-TACTGC-
CACTTCTGC-MGB-3′. 5 μl of extracted DNA were added to reactions
containing TaqMan Universal PCR Mix (Applied Biosystems), forward
and reverse primers (each at 200 nM ﬁnal concentration) and probe
(200 nM ﬁnal concentration) in a 25 μl reaction volume. Analysis on
an ABI Prism 7300 machine (Applied Biosystems) consisted of 40
cycles of 15 s at 90 °C and 60 s at 60 °C. Standard curves generated
using known amounts of plasmid containing the MAV-1 EIA gene
were used to convert cycle threshold values for experimental samples
to copy numbers of EIA DNA. Results were standardized to the ng
amount of input DNA. Each sample was assayed in triplicate.
Expression of the MAV-1 hexon gene was measured using RT-
qPCR. 2.5 μg of RNA were reverse transcribed using MMLV reverse
transcriptase (Invitrogen) in 20 μl reactions according to the
manufacturer's instructions. Primers and probe adapted from Lenaerts
et al. (2005) were used to detect a 167-bp region of the MAV-1 hexon
gene as follows: forward 5′-GGCCAACACTACCGACACTT-3′, reverse 5′-
31V.E. Anderson et al. / Virology 391 (2009) 25–32TTTTGTCCTGTGGCATTTGA-3′, and probe 5′-FAM-CATTCCAGCCAACT-
TATGGCTCGGC-TAMRA-3′. 2 μl of cDNA were added to a reaction
containing TaqMan Universal PCR Mix (Applied Biosystems), forward
and reverse primers (each at 200 nM ﬁnal concentration) and probe
(200 nM ﬁnal concentration) in a 25 μl reaction volume. Separate
reactions were prepared with 2 μl of cDNA, 1.25 μl of 20× mouse
GAPDH gene expression assay (Applied Biosystems) and TaqMan
Universal PCR Mix in a 25 μl reaction volume. In each case, RT-qPCR
analysis consisted of 40 cycles of 15 s at 90 °C and 60 s at 60 °C.
Standard curves generated using known amounts of plasmid contain-
ing the MAV-1 hexon gene or the mouse GAPDH gene were used to
convert cycle threshold values for experimental samples to copy
numbers of hexon and GAPDH transcripts, respectively. Copy numbers
of viral transcripts were normalized to copy numbers of GAPDH
transcripts for each sample. In a subset of samples prepared without
using reverse transcriptase, we veriﬁed that trace amounts of
contaminating DNA in the RNA samples contributed only a negligible
amount to hexon copies numbers detected using RT-qPCR.
Analysis of cytokine and mucus gene expression
Cytokine gene expression was quantiﬁed using RT-qPCR. cDNA
prepared as described above was ampliﬁed using gene expression
assays for mouse IL-4, IL-13 and GAPDH (Applied Biosystems). 2 μl of
cDNA were added to reactions containing TaqMan Universal PCR Mix
and 1.25 μl each of 20× gene expression assays for the target cytokine
and GAPDH. IFN-γwas detected using primers as follows: forward 5′-
AAAGAGATAATCTGGCTCTGC-3′ and reverse 5′-GCTCTGAGACAAT-
GAACGCT-3′. Expression of gob5 was detected using the primers:
forward 5′-GAGTGGGCTCACTTCCGATG-3′ and reverse 5′-GCTGAA-
CACCTCACTGCTTGG-3′; expression of muc5ac was detected using the
primers: forward 5′-CCAGCACCATCTCTACAACCC-3′ and reverse 5′-
GCAAAGCTCCTGTTTGCACTC-3′. For IFN-γ, gob5, and muc5ac, 2 μl of
cDNA were added to reactions containing TaqMan Power SYBR Green
PCRMix (Applied Biosystems) and forward and reverse primers (each
at 200 nM ﬁnal concentration) in a 25 μl reaction volume. Separate
reactions were prepared with TaqMan Power SYBR Green PCR Mix
(Applied Biosystems) and primers for mouse GAPDH (forward 5′-
TGCACCACCAACTGCTTAG-3′ and reverse 5′-GGATGCAGGGAT-
GATGTTC-3′ at 167 nM each). RT-qPCR analysis consisted of 40 cycles
of 15 s at 90 °C and 60 s at 60 °C. Quantiﬁcation of target gene
expression was normalized to GAPDH and expressed as fold change
from control groups using the comparative CT method (Fink et al.,
1998). We used ΔT values to calculate signiﬁcance between groups
and used 2−ΔΔT values for data presentation (Patrizio et al., 2007;
Yuan et al., 2006).
Histology
For two or more mice per experimental group at each time point,
the left lung was inﬂated with PBS to preserve lung architecture and
ﬁxed in 10% formalin. Organs were embedded in parafﬁn and 5 μm
sections were cut for histopathology. Sections were stained with
hematoxylin and eosin to evaluate cellular inﬁltrates. PAS stainingwas
performed to evaluate mucus production. Slides were viewed through
a Laborlux 12 microscope (Leitz). Digital images were obtained with
an EC3 digital imaging system (Leica Microsystems) using Leica
Acquisition Suite software (Leica Microsystems). Final images were
assembled using Adobe Illustrator (Adobe Systems).
To quantify mucus production, slides were examined in a blinded
fashion in order to count total airway lumens in a lung section
(minimum of 25 per section) and airway lumens with PAS staining in
the epithelium. These values were used to calculate the percentage of
PAS-staining airways in each lung section. To quantify cellular
inﬂammation in the lungs, slides were examined in a blinded fashion
to determine a pathology index as previously described (Cooke et al.,1996). Separate scores were generated for the severity of cellular
inﬁltrates around airway lumens and pneumonitis (alveolar and
interstitial inﬁltrates) according to the parameters outlined in Table 1.
Each score was multiplied by a number reﬂecting the extent of
involvement in the lung (5% to 25%=1, N25% to 50%=2, N50%=3).
The ﬁnal pathology index was obtained by adding together the values
for cellular inﬁltrates around airway lumens and pneumonitis,
resulting in a value that could range from 0 to 18.
Statistics
Analysis of data for statistical signiﬁcance was conducted using
Prism 3 for Macintosh (GraphPad Software, Incorporated). For viral
load and viral gene expression data, differences between groups at a
given time point were analyzed using the Mann–Whitney rank sum
test. Differences in lung viral loads between time points (Fig. 4C) were
analyzed using two-way analysis of variance (ANOVA) followed by
Bonferroni's multiple comparison tests. For cytokine and mucus gene
expression data, differences between ΔT values were analyzed using
the Mann–Whitney rank sum test for comparisons of two groups or
two-way ANOVA for comparison of more than two groups followed by
Bonferroni's multiple comparison tests to analyze differences
between two groups at each time point. For quantiﬁed PAS-staining
data and histological scoring, differences between multiple groups
were analyzed using two-way ANOVA with Bonferroni's multiple
comparison tests to analyze differences between two groups at each
time point. P values less than 0.05 were considered statistically
signiﬁcant.
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